Pang Phillip's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Feb 18, 2022
- Accession no.
- 0001209191-22-011338
- Filed
- Feb 18, 2022
- Trade date
- Feb 16-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $253.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pang PhillipCIK 0001787370 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $1.53 | +$7,650 | 97,777 | Direct | |
| Feb 16, 2022 | Common Stock | SSaleDisposed | −5,000 | $31.54 | −$157,700 | 92,777 | Direct | |
| Feb 17, 2022 | Common Stock | SSaleDisposed | −3,009 | $31.93 | −$96,077.37 | 89,768 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 52,591 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.